Google has announced an expansion of its Tag Diagnostics tool, which was initially launched in late June 2024, and introduced a new integrated Consent Management Platform (CMP) setup. These updates aim to help advertisers strengthen their first-party data strategies in the evolving digital privacy landscape.
Tag Diagnostics Expansion
The Tag Diagnostics feature, now available across Google Tag Manager, Google Ads, and Google Analytics, offers enhanced capabilities:
- In-UI health checks for Google tags
- At-a-glance view of account health
- Alerts for potential measurement issues
- Guidance on fixing identified problems
Tag Diagnostics monitors websites for issues such as:
- Missing conversion linker tags
- Incorrect command ordering in website code
- Absence of Google tags on related websites or pages
New Integrated Consent Management Setup
To simplify consent banner deployment and consent mode implementation, Google has launched an integrated solution with several CMP partners. Available within Google Ads, Google Analytics, and Google Tag Manager interfaces, this feature offers:
- In-product guidance tailored to specific setups
- Seamless integration with various CMP providers
- Simplified banner installation options
Launch partners for fully-integrated CMPs include:
- consentmanager
- Cookiebot by Usercentrics
- iubenda
- Usercentrics
These features aim to streamline the process of implementing consent management and building trust with customers, particularly in the European Economic Area (EEA). The rollout of the new CMP setup will occur gradually over the next few weeks across all accounts.
Google emphasizes that these tools are part of their ongoing commitment to helping businesses thrive in a first-party data-centric environment while respecting consumer privacy choices.
